BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4927485)

  • 1. Immunoglobulin G subclasses of antinuclear antibodies and renal deposits. Comparison of systemic lupus erythematosus, drug-induced lupus and rheumatoid arthritis.
    Kacaki JN; Callerame ML; Blomgren SE; Vaughan JH
    Arthritis Rheum; 1971; 14(2):276-82. PubMed ID: 4927485
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus.
    Weisbart RH; Yee WS; Colburn KK; Whang SH; Heng MK; Boucek RJ
    Ann Intern Med; 1986 Mar; 104(3):310-3. PubMed ID: 3511820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural antibody to procainamide and procainamide-induced systematic lupus erythematosus.
    Russel AS; Ziff M
    Ann Rheum Dis; 1969 May; 28(3):328. PubMed ID: 5305703
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on drug-induced lupus erythematosus in mice. 3. Renal lesions and splenomegaly in drug-induced lupus erythematosus.
    Veen JH Ten ; Feltkamp-Vroom TM
    Clin Exp Immunol; 1973 Dec; 15(4):591-600. PubMed ID: 4273216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoglobulin D detection and light chain type determination of antinuclear serum factors with the fluorescence antiglobulin test].
    Schmidt K; Mueller-Eckhardt C
    Klin Wochenschr; 1970 Jan; 48(2):128-9. PubMed ID: 4939533
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinuclear antibodies in some internal diseases, especially autoimmunization diseases.
    Lange A
    Arch Immunol Ther Exp (Warsz); 1972; 20(2):209-26. PubMed ID: 4112512
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 11. The serology of connective tissue disorders.
    Holborow EJ
    Br J Hosp Med; 1978 Mar; 19(3):250, 252, 257-8. PubMed ID: 343858
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD; Kerby GP
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.
    Klajman A; Camin-Belsky N; Kimchi A; Ben-Efraim S
    Clin Exp Immunol; 1970 Nov; 7(5):641-9. PubMed ID: 4099667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin.
    Burnham TK; Fine G
    Arch Dermatol; 1971 Jan; 103(1):24-32. PubMed ID: 4099590
    [No Abstract]   [Full Text] [Related]  

  • 15. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 18. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 19. Class specific antinuclear antibodies in systemic lupus erythematosus.
    Savitri K; Sehgal S; Datta BN; Chugh KS
    Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibody induced by procainamide. A prospective study.
    Blomgren SE; Condemi JJ; Bignall MC; Vaughan JH
    N Engl J Med; 1969 Jul; 281(2):64-6. PubMed ID: 4182059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.